Martina Geiger (Birk) is an accomplished scientist specializing in cancer immunotherapy, with experience at Roche from October 2017 to July 2020 in various roles including Scientist and Senior Scientist. During this time, primary responsibilities included the planning and generation of transient and stable vectors for antigen expression. Prior to her tenure at Roche, Martina engaged in research during a master's thesis at Altana Pharma, focusing on the mitotic spindle checkpoint's impact on chemosensitivity, resulting in a publication in the International Journal of Cancer. Additionally, a research internship at AID Autoimmun Diagnostika GmbH involved detecting Single Nucleotide Polymorphisms in human DNA and identifying HPV strains linked to cervical cancer. Educational qualifications include a Bachelor's Degree in Biological Chemistry and a Master's Degree in Molecular Toxicology and Plant Physiology from the University of Constance, as well as a doctoral degree (Dr. rer. hum. biol.) from Ludwig-Maximilians Universität München.
This person is not in the org chart
This person is not in any teams
This person is not in any offices